Beclin-1 immunolabeling level was investigated as a prognostic and predictive markerin multiple human neoplasms,8,17,23,33,53 and its role as a prognostic marker appears to be dependent on the type ofcancer. This evidence concerns the gene BECN1 and neoplasm.